STOCKS TELEGRAPH

Tag: PLXP STOCK PRICE

  • How PLXP Stock Expanded In Afterhours Trades?

    How PLXP Stock Expanded In Afterhours Trades?

    At the last check, PLx Pharma Inc. (PLXP) shares were trading at $19.50, an increase of 14.84 percent in after-hours trading. PLXP stock rose 1.68% on Monday to close at $16.98. On the day, 0.73 million shares of PLXP stock were traded, which was higher than the average daily volume of 0.46 million shares. In the last 12 months, shares of PLXP have risen 487.54%, and they have risen 36.60% in the last week.

    Over the past three months, PLXP has seen its stock rise 61.56%, but over the past six months, it has tumbled 185.79%. In addition, PLXP is currently listed at $392.41 million on the market and its shares outstanding stand at 22.98 million. As part of its business strategy concerning expanding the availability of VAZALORE, PLXP stock rose.

    How did PLXP make that move?

    PLx is a specialty pharmaceutical company whose PLxGuard drug delivery platform has been clinically validated and is patent-protected, and which is dedicated to creating safer products and more effective therapies. The PLxGuard drug delivery platform allows PLXP to target pharmaceutical ingredients to specific regions of the gastrointestinal (GI) tract. Through the platform PLXP has developed, many drugs that are currently available or are in development could be better absorbed and increase the risk of stomach erosions and ulcers associated with certain drugs. PLXP’s leading products include VAZALORE 325 mg and VAZALORE 81 mg, referred to collectively as “VAZALORE”.

    PLx announced that more than 8,000 Walgreens locations nationwide will begin to offer three stock-keeping units (SKUs) of VAZALORE ” a liquid-filled aspirin capsule that is first and only capsule approved by the Food and Drug Administration (FDA).

    • The Walgreens chain of retail pharmacies is among the world’s leading brands.
    • In order to reserve floor space at Walgreens for all three SKUs: VAZALORE 81 mg, 12 count; VAZALORE 81 mg, 30 count; and VAZALORE 325 mg, 30 count, placeholders have already been placed.
    • PLXP has moved ahead with its commercial launch plans by partnering with Walgreens, which will carry all three SKUs of VAZALORE in over 8,000 of the company’s stores.
    • Walmart’s health and wellbeing focus is aligned with PLXP’s aim of bringing VAZALORE to as many people as possible so they can benefit from PLXP’s unique aspirin therapy.

    What PLXP has announced previously?

    PLx (PLXP) last week announced that its VAZALORE products will be sold at more than 4,500 Walmart stores in the United States by mid-August. As a result, Walmart has already inserted placeholders on the shelves to alert customers about the arrival of PLXP’s VAZALORE. At the time, Walmart committed to stocking all three VAZALORE product SKUs in the next few weeks, using “Coming Soon” placeholder shelves.

  • Here is why PLx Pharma Inc. (PLXP) stock turnaround in the after-hours on Monday?

    Here is why PLx Pharma Inc. (PLXP) stock turnaround in the after-hours on Monday?

    PLx Pharma Inc. (PLXP) shares surged 28.56% in after-hours on Monday, July 112, 2021, and closed the daily trading at $15.98 per share. Earlier in the morning session, PLXP’s stock lost 3.27% to close Monday’s normal trading session at $12.43. PLXP shares have risen 337.68% over the last 12 months, and they have moved down 5.98% in the past week. Over the past three months, the stock has gained 26.71%, while over the past six months, it has lost105.45%.

    Let’s have a brief look at its recent news.

    Launch of VAZALORE in Walmart stores nationwide

    On July 12, 2021, PLx Pharma Inc announced the availability of VAZALOREin 3 SKUs over 4,500 Walmart stores across the United States from mid-August.VAZALORE is the first and only U.S. Food and Drug Administration (FDA) approved liquid-filled aspirin capsules.

    The three SKUs are VAZALORE 81 mg, 12 count; VAZALORE 81 mg, 30 count; and VAZALORE 325 mg, 30 count.

    Participation in the recent healthcare conferences

    PLx Pharma Inc recently participated at the Raymond James Human Health Innovation Conference which held on Monday, June 21, 2021.

    The company also took part in The JMP Securities Life Sciences Conference which held on Wednesday, June 16, 2021.

    At both conferences, the company was presented by Natasha Giordano, President and Chief Executive Officer, and Rita O’Connor, Chief Financial Officer.

    Recent financial results announcement

    On May 14, 2021, PLx Pharma Inc announced its financial results for the first quarter of 2021 which ended on March 31, 2021.

    Q1 2021 financial highlights

    PLx Pharma Inc reported zero revenue for Q1 2021 compared to $2,523 for the first quarter of 2020.

    In Q1 2021, research and development expenses were $1.0 million compared to $0.5 million in Q1 2020.

    General and administrative expenses were $2.6 million in Q1 2021 compared to $2.5 million in the first quarter of 2020.

    The company suffered a net loss of $11.9 million, or $0.73 per basic and diluted share in Q1 2021, compared to net income of $1.2 million, or $0.08 per basic and diluted share, for the first quarter of 2020.

    The Company had cash and cash equivalents of $84.4 million on March 31, 2021.

    Q4 and FY 2020 financial results announcement

    On March 12, 2021, PLx Pharma Inc announced financial results for the three months and full-year ended December 31, 2020.

    Q4 2020 financial highlights

    • The company earned zero revenue in Q4 2020 compared to $24,000 for the fourth quarter of 2019.
    • In Q4 2020, research and development expenses were $1.2 million compared to $0.9 million in the fourth quarter of 2019.
    • General and administrative expenses were $2.5 million in the fourth quarter of 2020 compared to $2.8 million in the fourth quarter of 2019.
    • PLx Pharma suffered a net loss of 5 million, or $0.87 per basic and diluted share in Q4 2020, compared to a net loss of $2.3 million, or $0.25 per share, for the fourth quarter of 2019.

    Conclusion

    The launching of VAZALORE nationwide in Walmart stores is big news for the company due to which its stock price surged in the after-hours on Monday. We can expect it to rise significantly in the coming days.